PMC:7317273 / 13567-13909 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T97","span":{"begin":165,"end":169},"obj":"Body_part"}],"attributes":[{"id":"A97","pred":"fma_id","subj":"T97","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"22- NCT043\n48,435 A Randomized,\nDouble-Blind,\nPlacebo-Controlled\nClinical Trial to Determine the Safety and Efficacy of Hope\nBiosciences\nAllogeneic\nMesenchymal Stem\nCell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: April 2020\nDOC: April 2021 Both Child,\nAdult, Older\nAdult United States"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T78","span":{"begin":219,"end":226},"obj":"Disease"},{"id":"T79","span":{"begin":258,"end":260},"obj":"Disease"}],"attributes":[{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"}],"text":"22- NCT043\n48,435 A Randomized,\nDouble-Blind,\nPlacebo-Controlled\nClinical Trial to Determine the Safety and Efficacy of Hope\nBiosciences\nAllogeneic\nMesenchymal Stem\nCell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: April 2020\nDOC: April 2021 Both Child,\nAdult, Older\nAdult United States"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T150","span":{"begin":0,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T151","span":{"begin":18,"end":19},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T152","span":{"begin":165,"end":169},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"22- NCT043\n48,435 A Randomized,\nDouble-Blind,\nPlacebo-Controlled\nClinical Trial to Determine the Safety and Efficacy of Hope\nBiosciences\nAllogeneic\nMesenchymal Stem\nCell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: April 2020\nDOC: April 2021 Both Child,\nAdult, Older\nAdult United States"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T63","span":{"begin":227,"end":229},"obj":"Chemical"},{"id":"T64","span":{"begin":258,"end":260},"obj":"Chemical"},{"id":"T65","span":{"begin":282,"end":285},"obj":"Chemical"}],"attributes":[{"id":"A63","pred":"chebi_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A64","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_73803"},{"id":"A65","pred":"chebi_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/CHEBI_16973"}],"text":"22- NCT043\n48,435 A Randomized,\nDouble-Blind,\nPlacebo-Controlled\nClinical Trial to Determine the Safety and Efficacy of Hope\nBiosciences\nAllogeneic\nMesenchymal Stem\nCell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: April 2020\nDOC: April 2021 Both Child,\nAdult, Older\nAdult United States"}

{"project":"LitCovid-PubTator","denotations":[{"id":"178","span":{"begin":303,"end":308},"obj":"Species"},{"id":"201","span":{"begin":219,"end":229},"obj":"Disease"}],"attributes":[{"id":"A178","pred":"tao:has_database_id","subj":"178","obj":"Tax:9606"},{"id":"A201","pred":"tao:has_database_id","subj":"201","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"22- NCT043\n48,435 A Randomized,\nDouble-Blind,\nPlacebo-Controlled\nClinical Trial to Determine the Safety and Efficacy of Hope\nBiosciences\nAllogeneic\nMesenchymal Stem\nCell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: April 2020\nDOC: April 2021 Both Child,\nAdult, Older\nAdult United States"}

{"project":"LitCovid-sentences","denotations":[{"id":"T238","span":{"begin":0,"end":10},"obj":"Sentence"},{"id":"T239","span":{"begin":11,"end":31},"obj":"Sentence"},{"id":"T240","span":{"begin":32,"end":45},"obj":"Sentence"},{"id":"T241","span":{"begin":46,"end":64},"obj":"Sentence"},{"id":"T242","span":{"begin":65,"end":124},"obj":"Sentence"},{"id":"T243","span":{"begin":125,"end":136},"obj":"Sentence"},{"id":"T244","span":{"begin":137,"end":147},"obj":"Sentence"},{"id":"T245","span":{"begin":148,"end":164},"obj":"Sentence"},{"id":"T246","span":{"begin":165,"end":270},"obj":"Sentence"},{"id":"T247","span":{"begin":271,"end":281},"obj":"Sentence"},{"id":"T248","span":{"begin":282,"end":286},"obj":"Sentence"},{"id":"T249","span":{"begin":287,"end":309},"obj":"Sentence"},{"id":"T250","span":{"begin":310,"end":322},"obj":"Sentence"},{"id":"T251","span":{"begin":323,"end":342},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"22- NCT043\n48,435 A Randomized,\nDouble-Blind,\nPlacebo-Controlled\nClinical Trial to Determine the Safety and Efficacy of Hope\nBiosciences\nAllogeneic\nMesenchymal Stem\nCell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: April 2020\nDOC: April 2021 Both Child,\nAdult, Older\nAdult United States"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T183","span":{"begin":219,"end":239},"obj":"SP_7"},{"id":"T184","span":{"begin":310,"end":315},"obj":"UBERON:0007023"}],"text":"22- NCT043\n48,435 A Randomized,\nDouble-Blind,\nPlacebo-Controlled\nClinical Trial to Determine the Safety and Efficacy of Hope\nBiosciences\nAllogeneic\nMesenchymal Stem\nCell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: April 2020\nDOC: April 2021 Both Child,\nAdult, Older\nAdult United States"}